Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| D004211 | Disseminated Intravascular Coagulation NIH | 0.50 |
| D020141 | Hemostatic Disorders NIH | 0.26 |
| D001778 | Blood Coagulation Disorders NIH | 0.26 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0005521 | Disseminated intravascular coagulation HPO | 0.50 |
| HP:0001928 | Abnormality of coagulation HPO | 0.26 |
Navigate: Correlations HPO
There is one clinical trial.
This study will study the potential utility of the Quantra QPlus System in patients inflicted with COVID-19 disease.
Description: Coagulation function assessed by the Quantra
Measure: Quantra Clot Time results Time: Within 24 hours of admission to the hospitalDescription: Coagulation function assessed by the Quantra
Measure: Quantra Clot Time results Time: 48 to 72 hours after transfer to ICUDescription: Coagulation function assessed by the Quantra
Measure: Quantra Clot Time results Time: 1 to 24 hours prior to discharge from hospitalDescription: Coagulation function assessed by the Quantra
Measure: Quantra Clot Stiffness results Time: Upon arrival at hospitalDescription: Coagulation function assessed by the Quantra
Measure: Quantra Clot Stiffness results Time: 48 to 72 hours after transfer to ICUDescription: Coagulation function assessed by the Quantra
Measure: Quantra Clot Stiffness results Time: 1 to 24 hours prior to discharge from hospitalAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports